RESUMEN
This longitudinal study investigated social capital as a way through which youths' organized activities promote their future adjustment. Specifically, we examined social mediators of the associations between intensity, duration, and breadth of participation from age 14 to 17 and adjustment at age 18. Two social mediators were tested: support from the activity leader and social integration into the activity peer group. In addition, we examined how these mediation effects vary across gender. The sample consisted of 228 French Canadian adolescents (65 % girls). Youths were surveyed yearly from age 12 to 18. Controlling for prior adjustment at age 12, greater duration of participation from age 14 to 17 was associated with lower problematic alcohol use and higher civic engagement at age 18 through support from the activity leader. In addition, for boys only, greater duration of participation was associated with fewer subsequent depressive symptoms through social integration into the activity peer group. Overall, our results suggest that sustained participation allows youths to develop positive social experiences within organized activities, which, in turn, promote their future adjustment. Moreover, boys might benefit more from social experiences in organized activities than girls, at least with respect to depressive symptoms.
Asunto(s)
Actividades Cotidianas/psicología , Conducta del Adolescente/psicología , Autoeficacia , Identificación Social , Apoyo Social , Adolescente , Canadá , Femenino , Humanos , Estudios Longitudinales , Masculino , Grupo Paritario , Trabajo/psicologíaRESUMEN
This study assessed the stability of six extemporaneously compounded hydroxyurea oral liquids stored at room temperature. Hydroxyurea oral liquids (100 mg/mL) were prepared using three different mixing methods (mortar, mixer or QuartetRx) from either bulk powder, capsule content, or whole capsules. Two brands of capsules were tested in this study. All formulations were stored at room temperature (25°C / 60% RH) in amber plastic bottles for 90 days and amber plastic syringes for 14 days. Physical stability was assessed visually, while chemical stability was evaluated using a stability-indicating high-performance liquid chromatography method. Chemical derivatization with xanthydrol allowed the retention of hydroxyurea on a reverse-phase column. At least 93.9% and 97.0% of the initial concentration of hydroxyurea remained after 90 days in bottles and 14 days in syringes, respectively. There were no visual changes in formulations over the study period. Changes in pH up to 1.6 units were observed after 90 days of storage and were explained most likely by an ammonium generating degradation pathway. Ammonium was quantified and remained within safe levels in each HU 100 mg/mL oral preparations. Hydroxyurea oral liquids were all stable for 90 days in amber plastic bottles and 14 days in amber plastic syringes.
Asunto(s)
Compuestos de Amonio , Hidroxiurea , Administración Oral , Ámbar , Cápsulas , Cromatografía Líquida de Alta Presión , Composición de Medicamentos , Estabilidad de Medicamentos , Almacenaje de Medicamentos , Plásticos , SuspensionesRESUMEN
OBJECTIVE: The aim of this study was to review the use of patient-controlled analgesia (PCA) in sickle cell disease (SCD) for pediatric patients with vaso-occlusive crisis (VOC) in our institution and to compare the effect of early vs late PCA start on pain relief and LOS. METHODS: This retrospective study included all pediatric patients treated with PCA for a severe VOC from 2010 to 2016. "Early-PCA" was defined as start of PCA within 48 hours of arrival. Time to reach adequate analgesia was defined as the time to reach 2 consecutive pain scores less than 5/10 at 4-hour interval. RESULTS: During the study period, 46 patients presented 87 episodes of VOC treated with PCA. Sixty-three patients with VOC were treated with Early-PCA and 24 with Late-PCA. Both groups were comparable except for median pain score at admission; the Early-PCA group had higher scores: 9.0/10 vs 7.0/10. Time to reach adequate analgesia could be evaluated only in a subset of patients (n = 32) but was shorter in the Early-PCA group with a median difference of 41.0 hours (95% CI -82.0 to -6.0). Early-PCA was associated with a median reduction in LOS of 3.4 days (95% CI -4.9 to -1.9). There was no difference between the 2 groups in terms of side effects and occurrence of acute chest syndrome during hospitalization. CONCLUSIONS: In this study, a reduced time to reach adequate analgesia and LOS was noted in the Early-PCA group for severe VOC. A prospective study is required to confirm these results.